NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Becomes First Commercial Site to Deploy Zeta Surgical's FDA-Cleared Zeta TMS Navigation System

Deployment at HOPE's West Palm Beach clinic brings AI-powered, sub-millimetric image guidance to the delivery of Transcranial Magnetic ...

MagVenture Receives FDA Clearance for Accelerated TMS Protocols, Expanding Flexibility for Clinics and Patients

ALPHARETTA, GA, UNITED STATES, May 26, 2026 /EINPresswire.com/ -- MagVenture®, a global leader in non-invasive ...
Monthly Prescribing Reference

Magstim TMS System Cleared for Adolescents With Major Depressive Disorder

The FDA clearance now allows physicians and nurse practitioners to gain authorization from insurance providers to treat adolescent patients. The Food and Drug Administration (FDA) has cleared ...
Monthly Prescribing Reference

Magstim Horizon Inspire TMS System Cleared for Depression, OCD Treatment

The Horizon® 3.0 Inspire has a compact design allowing for easier portability. The Food and Drug Administration (FDA) has cleared Magstim’s Horizon ® 3.0 Inspire for the treatment of major depressive ...

ZETA SURGICAL Announces First Commercial Deployment of Zeta TMS Navigation System at HOPE Therapeutics

ZETA SURGICAL today announced the first commercial deployment of its FDA-cleared Zeta TMS Navigation System. The system will be utilized at HOPE Therapeutics in West Palm Beach, Florida, to deliver ...